Treatment outcome of post-streptococcal acute glomerulonephritis and its associated factors among children less than 15 years at the referral hospital of East Amhara, Ethiopia.

IF 1.6 Q2 MULTIDISCIPLINARY SCIENCES BMC Research Notes Pub Date : 2024-10-17 DOI:10.1186/s13104-024-06971-w

Leweyehu Alemaw Mengstie, Taye Tesfa, Samrawit Addisu, Sisay Shewasinad

引用次数: 0

Abstract

Objectives: Aimed to assess the treatment outcome of post-streptococcal acute glomerulonephritis and its associated factor among children of less than 15 years at a referral hospital in Amhara Northeast Ethiopia, 2022.

Results: In this study, 322 Post- post-streptococcal acute glomerulonephritis children with a response rate of 97% were included. Of these, 33.54% of them had a poor treatment outcome. Age less than or equal to 5 years (AOR = 3.2, 95% CI (1.5-7.3), Creatinine level > 1.3 mg/dl (AOR = 5.5,95% CI (2.5-11.7), blood urea nitrogen leve ≥ 119 mg/dl (AOR = 4.9,95% CI (1.1-19) and length of stay > 10 days(AOR = 2.6,95% CI (1.18-5.9) were statistically significant with poor outcome of children with post-streptococcal acute glomerulonephritis and management during admission to reduce poor treatment outcomes.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

埃塞俄比亚东阿姆哈拉转诊医院 15 岁以下儿童链球菌感染后急性肾小球肾炎的治疗结果及其相关因素。

目的旨在评估2022年埃塞俄比亚阿姆哈拉东北部一家转诊医院15岁以下儿童链球菌感染后急性肾小球肾炎的治疗效果及其相关因素：本研究共纳入 322 名链球菌感染后急性肾小球肾炎患儿，应答率为 97%。其中，33.54%的患儿治疗效果不佳。年龄小于或等于 5 岁（AOR = 3.2，95% CI (1.5-7.3)）、肌酐水平大于 1.3 mg/dl（AOR = 5.5，95% CI (2.5-11.7)）、血尿素氮水平≥ 119 mg/dl（AOR = 4.9，95% CI (1.1-19)）和住院时间大于 3 个月。1-19）和住院时间大于 10 天（AOR = 2.6，95% CI (1.18-5.9)）与链球菌感染后急性肾小球肾炎患儿的不良预后有统计学意义，入院期间的管理可减少不良治疗预后。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

BMC Research Notes Biochemistry, Genetics and Molecular Biology-Biochemistry, Genetics and Molecular Biology (all)

CiteScore

3.60

自引率

0.00%

发文量

363

审稿时长

15 weeks

期刊介绍： BMC Research Notes publishes scientifically valid research outputs that cannot be considered as full research or methodology articles. We support the research community across all scientific and clinical disciplines by providing an open access forum for sharing data and useful information; this includes, but is not limited to, updates to previous work, additions to established methods, short publications, null results, research proposals and data management plans.